Latest News about NVO
Recent news which mentions NVO
Tickers
NVO
From Motley Fool
From Motley Fool
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
August 12, 2024
From Benzinga
Weight Loss Stocks Could Become Alzheimer's Drugs Stocks. Here's Why That's Bullish for Novo Nordisk
August 12, 2024
Tickers
NVO
From Motley Fool
Eli Lilly's Q2 Sales Surge 36%, Analysts Cautious On Future Supply, Market Dynamics; Optimistic About Next-Gen Oral Weight-Loss Drug
August 09, 2024
From Benzinga
From Motley Fool
Tickers
NVO
From Motley Fool
Here's Why Eli Lilly Stock Dropped 12% Last Month
August 08, 2024
From Motley Fool
Novo Nordisk Withdraws Wegovy FDA Heart Failure Submission, Terminates Development Of Two Early Stage Assets
August 07, 2024
From Benzinga
From Benzinga
Why Shares of Wegovy Maker Novo Nordisk Are Tumbling Today
August 07, 2024
Tickers
NVO
From Motley Fool
What's Going On With Eli Lilly And Company Shares Wednesday?
August 07, 2024
From Benzinga
Weight-Loss Giant Novo Nordisk Tumbles To 200-Day Average Support: 'Weakness Could Be Buying Opportunity,' Analyst Says
August 07, 2024
Tickers
NVO
From Benzinga
Ozempic-Maker Novo Nordisk Reveals Patients Stay On Wegovy Weight-Loss Drug For 6 Months Due To Low Availability
August 07, 2024
From Benzinga
Tickers
NVO
From InvestorPlace
Is It Too Late to Buy Novo Nordisk Stock After Its 57% Surge?
August 07, 2024
From Motley Fool
Novo Nordisk Tumbles 3% In Wednesday Premarket: What's Causing 'Miracle' Weight Loss Drug Ozempic Maker's Stock Slide?
August 07, 2024
From Benzinga
From Benzinga
After Ozempic And Botox, Hollywood Is Going Gaga Over This New Anti-Aging Supplement
August 05, 2024
From Benzinga
3 Unstoppable Stocks to Buy in August
August 03, 2024
From Motley Fool
Eli Lilly vs Novo Nordisk: A Recent Study Suggests This Company Has the Best Weight Loss Drug
August 03, 2024
From Motley Fool
Using Weight Loss Medications Such As Wegovy, Zepbound? Psychologist Warns Of Linked Eating Disorder Risks
August 02, 2024
From Benzinga
From Benzinga
Hims & Hers Stock Is Looking to Cash in From the GLP-1 Hype, but Will Its Controversial Strategy Pay Off?
August 02, 2024
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
